Phase 3 Randomized Study of Loncastuximab Tesirine plus Rituximab versus Immunochemotherapy in Patients with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) – LOTIS-5
Email this document.
Enter your email address below to send this document.